Phase
Preclinical & Translational
Once programs leave pure discovery, the demands change. Biology must withstand pressure. Evidence must connect molecular findings to real outcomes. This is where translational clarity sets the tone for the rest of the development.
What companies need at this stage
Teams aim to understand mechanisms, build predictive biomarkers, and design preclinical studies that can be translated. They need confidence that what works in model systems will hold true in human biology.
BioLizard solutions
- Deep multi-omics integration to unite transcriptomics, proteomics, metabolomics, and clinical annotations.
- Mechanism of action analysis through pathway, network, and causal tools.
- PK and PD biomarker frameworks that stand up in later phases.
- Animal to human translation models that preserve biological meaning.
- QC and validated workflows ready for IND packages.
Relevant Bio|Verse® modules
Bio|Mx® anchors translational insight. Dashboards let teams track biomarkers, explore mechanistic patterns, and compare preclinical and human data.
Explore →
Modular offerings
Multi-omics modeling | Digital twin simulations | Proteomics and metabolomics pipelines | IND and IMPD data structures
Explore all solutions →
Exploring target expression and identifying other indications with a similar mode of action
The client wanted to study the expression of their target gene within two known indications and to uncover other diseases where the target has a similar mode of action. Identifying comparable indications could strengthen the business case for further development. Our...
Identifying virulence factors in an opportunistic pathogenic bacterium
The client wanted to confirm and identify virulence factors in a gut bacterium that normally resides harmlessly in animals but can cause infection under stress or immunosuppression. Population structure complicated the distinction between pathogenic and commensal...
Unlocking immunogenicity insights from clinical reports with NLP
Most information about the immunogenicity of therapeutic peptides is locked in unstructured clinical reports. The client wanted to extract and structure this data to inform development of safe and effective treatments. Our Approach We built a robust extraction...